Yann Echelard sold $369K of TG Therapeutics (TGTX)

Executed Jun 13 2025, disclosed Jun 16 2025, 3 days later.

Value, as filed

$369K

10,000 sh × $36.94

Executed

Jun 13 2025

the trade date, as filed

Disclosed

Jun 16 2025

3 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

YE Yann Echelard Director profile →

Yann Echelard (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in TG Therapeutics, Inc. (TGTX). The largest single filing was $163K of TGTX (5,000 sh × $32.57, as filed), executed Nov 24 2025.

The name

TGTX TG Therapeutics, Inc. TGTX · Healthcare · 8 filings in 24 months ticker →

Healthcare · TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of nove…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Yann Echelard in TGTX

TGTXSALE TG Therapeutics, Inc. $163K
5,000 sh × $32.57
Exec Nov 24 2025
Filed Nov 25 2025 · 5:30 PM ET TGTXSALE TG Therapeutics, Inc. $490K
20,000 sh × $24.48
Exec Nov 5 2024
Filed Nov 7 2024 · 5:30 PM ET